NewcelX CSO Revel Michel reports initial holdings

NewcelX Ltd. CSO and director Revel Michel filed an initial ownership report.

Rhea-AI Filing Summary

NewcelX Ltd. CSO and director Revel Michel filed an initial ownership report. He directly holds 940,787 ordinary shares and options on 9,117 ordinary shares at an exercise price of $7.6200 expiring on November 4, 2035. As of this filing, 759 option shares are vested and exercisable, with the remainder vesting in 11 equal quarterly installments beginning May 4, 2026, subject to his continued service. Certain option grants are held through a trustee to qualify for Israeli tax benefits under Section 102 of the Israeli Tax Ordinance.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Revel Michel

Role CSO and Director

Type	Security	Shares	Price	Value
holding	Option to Purchase Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Option to Purchase Ordinary Shares — 9,117 contracts (Direct); Ordinary Shares — 940,787 shares (Direct)

Footnotes (2)

1. F1. As of the date of this Form 3, options to purchase 759 ordinary shares are vested and currently exercisable. The remaining options vest and become exercisable beginning on May 4, 2026 in 11 equal installments on a quarterly basis, subject to the Reporting Person's continued service.
2. F2. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in the name of a trustee.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Revel Michel’s Form 3 filing for NewcelX Ltd. (NCEL) show?

The Form 3 shows CSO and director Revel Michel’s initial ownership in NewcelX. He holds 940,787 ordinary shares directly plus options on 9,117 ordinary shares, providing a detailed snapshot of his equity stake at the reporting date.

How many NewcelX (NCEL) shares does Revel Michel directly own?

Revel Michel directly owns 940,787 ordinary shares of NewcelX. This direct holding reflects his current equity position in the company’s ordinary shares as reported in the Form 3, separate from any options or other derivative securities.

What stock options does Revel Michel hold in NewcelX (NCEL)?

He holds options to purchase 9,117 NewcelX ordinary shares at an exercise price of $7.6200, expiring November 4, 2035. These options give him the right, but not obligation, to buy additional shares at that price before expiration.

How are Revel Michel’s NewcelX (NCEL) options vesting over time?

As of the Form 3 date, options for 759 ordinary shares are vested and exercisable. The remaining options vest in 11 equal quarterly installments beginning May 4, 2026, conditional on his continued service with NewcelX throughout the vesting period.

Why are some NewcelX (NCEL) options held through a trustee for Revel Michel?

To qualify for tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in a trustee’s name, so certain options are held by a trustee on his behalf.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:05 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Revel Michel

(Last) (First) (Middle)

C/O NEWCELX LTD.

THE CIRCLE 6

(Street)

ZURICH 8058

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NewcelX Ltd. [ NCEL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CSO and Director

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	940,787	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Ordinary Shares	(1)	11/04/2035	Ordinary Shares	9,117(2)	$7.62	D

Explanation of Responses:

1. As of the date of this Form 3, options to purchase 759 ordinary shares are vested and currently exercisable. The remaining options vest and become exercisable beginning on May 4, 2026 in 11 equal installments on a quarterly basis, subject to the Reporting Person's continued service.

2. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the NewcelX Ltd. Share Option Plan Regulation 2021 must be registered in the name of a trustee.

	/s/ Michel Revel	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)